JAMA Netw Open:早期儿童教育可能有助于预防中年心血管疾病

2021-08-23 MedSci原创 MedSci原创

几十年来,儿童教育和中年心血管疾病发病风险一直是国际发展议程的核心。然而,教育程度与心血管疾病发病风险仍然未被充分认识。

几十年来,儿童教育和中年血管疾病发病风险一直是国际发展议程的核心。然而,教育程度与心血管疾病发病风险仍然未被充分认识。迄今为止,很少有大型研究评估儿童教育与中年心血管疾病发病风险之间的关联。

pixabay

近日,发表在JAMA Netw Open杂志的一项研究,对来自芝加哥纵向研究的 3 9 岁的1539 名参与者进行探索分析发现,全面而成熟的儿童教育计划可能会促进中年人的心血管的健康,这与心血管疾病的长期风险有关。

在这项研究中,研究人员使用芝加哥纵向研究中的黑人和西班牙裔儿童队列,该队列研究自1983年至1989年期间参加了一个既定的儿童早期计划或常规服务,并随访30年。同时,参与者在37岁时进行了一项关于幸福感的中年问卷调查。

结果显示,共收纳了 1539 名参与者,其中1430 名黑人参与者,108 名西班牙裔参与者,1 名白人参与者 。有1104名参与者在 37 岁时完成了一项关于幸福感的中年问卷调查,1060 名参与者的问卷可用于分析数据,平均年龄为34.9岁,565名为女性。

教育程度介导因素前后FRS评分差异

通过倾向评分加权调整 17 项基线属性和差异磨损后,对学龄前儿童进行干预的总体硬弗雷明汉风险评分 (FRS)显著降低,心血管疾病风险降低 20%学龄前教育最大减少是 H-FRS 前四分位数的比例,约为26%G-FRS 的中位风险或更高风险类别减少 19%。对于学龄前至3年级组,中位风险或更高风险类别的降低分别为 16% 15%

综上所述,尽管该研究样本特征也是同质的,可能无法推广到低收入黑人人口之外,但结论依旧具有参考性,早期儿童教育可能有助于预防中年心血管疾病。

原始出处

Arthur J. Reynolds, PhD1; Suh-Ruu Ou, PhD1Lauren Eales, MA2; et al.Assessment of a Comprehensive Early Childhood Education Program and Cardiovascular Disease Risk in Midlife.JAMA Netw Open. 2021;4(8):e2120752. doi:10.1001/jamanetworkopen.2021.20752

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1729091, encodeId=e31c1e29091e6, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jul 09 05:59:31 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734414, encodeId=0e6c1e34414e2, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Jun 16 23:59:31 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498929, encodeId=5e55149892980, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 25 06:59:31 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010725, encodeId=a3051010e2514, content=这个立项点,绝!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Mon Aug 23 21:06:12 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036799, encodeId=9e031036e99e0, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Aug 23 18:59:31 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2022-07-09 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1729091, encodeId=e31c1e29091e6, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jul 09 05:59:31 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734414, encodeId=0e6c1e34414e2, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Jun 16 23:59:31 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498929, encodeId=5e55149892980, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 25 06:59:31 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010725, encodeId=a3051010e2514, content=这个立项点,绝!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Mon Aug 23 21:06:12 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036799, encodeId=9e031036e99e0, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Aug 23 18:59:31 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2022-06-16 canlab
  3. [GetPortalCommentsPageByObjectIdResponse(id=1729091, encodeId=e31c1e29091e6, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jul 09 05:59:31 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734414, encodeId=0e6c1e34414e2, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Jun 16 23:59:31 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498929, encodeId=5e55149892980, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 25 06:59:31 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010725, encodeId=a3051010e2514, content=这个立项点,绝!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Mon Aug 23 21:06:12 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036799, encodeId=9e031036e99e0, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Aug 23 18:59:31 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1729091, encodeId=e31c1e29091e6, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jul 09 05:59:31 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734414, encodeId=0e6c1e34414e2, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Jun 16 23:59:31 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498929, encodeId=5e55149892980, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 25 06:59:31 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010725, encodeId=a3051010e2514, content=这个立项点,绝!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Mon Aug 23 21:06:12 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036799, encodeId=9e031036e99e0, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Aug 23 18:59:31 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-08-23 仓央嘉措

    这个立项点,绝!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1729091, encodeId=e31c1e29091e6, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sat Jul 09 05:59:31 CST 2022, time=2022-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1734414, encodeId=0e6c1e34414e2, content=<a href='/topic/show?id=d4f412668a4' target=_blank style='color:#2F92EE;'>#NET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12668, encryptionId=d4f412668a4, topicName=NET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ea033781210, createdName=canlab, createdTime=Thu Jun 16 23:59:31 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498929, encodeId=5e55149892980, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Aug 25 06:59:31 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010725, encodeId=a3051010e2514, content=这个立项点,绝!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210818/fb5e13970d3f4b33ad2f87e78533b788/2bf64a46b2af4889a9670b2c45628c79.jpg, createdBy=b99c5577202, createdName=仓央嘉措, createdTime=Mon Aug 23 21:06:12 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036799, encodeId=9e031036e99e0, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Mon Aug 23 18:59:31 CST 2021, time=2021-08-23, status=1, ipAttribution=)]
    2021-08-23 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Stroke:新概念“认知功能储备”对脑卒中患者认知功能影响如何?

由于不同个体对于临床神经病认知损害具有差异性,才引入了认知储备(CR)的理论。本研究旨在评价是否CR对脑卒中后认知损害因素及认知功能恢复具有影响。

Alzheimer's Dementia: 中国-瑞典联合研究:高等教育,可缓冲中年抑郁症对痴呆的影响

中国-瑞典联合研究:高等教育,可缓冲中年抑郁症对痴呆的影响

民进中央拟向政协大会提交提案46件 关注教育经济医卫等领域发展

全国政协十三届四次会议召开在即。民进中央目前已形成拟提交此次政协大会的党派提案46件,提案涉及教育、文化、出版、经济、科技医疗卫生、资源环境等领域内容。

战疫者|宜昌护士:临行前母亲说后悔让我学医,但我心意已决

在这场艰苦而危机四伏的战役中,作为医务工作者,向望渴望能做个“战士”,奔赴抗击疫情的第一线。

不可思议的台湾医疗:我们可以向它学习什么?

台湾有2300万人口,平均寿命高达80岁,台湾医疗更是被誉为亚洲的奇迹。在《看医界》前不久刊发的文章《一家民营医院竟然颠覆了整个医疗体系!》中,介绍了长庚医院的管理经验,那么放眼整个台湾,民营医疗的发展经历了哪些阶段?对大陆又有哪些借鉴意义?

Medicine:灵活的健康教育模式可提高中国西藏孕妇的依从性

产前检查是预防高危妊娠、保障母婴安全的关键措施。然而,西藏自治区林芝地区的孕妇由于医疗机构有限、医护人员不足、医疗设备缺乏等原因,往往不能定期进行产前检查。健康教育是解决西藏农村孕妇这一日益严重的问题